Full Press Release Details
Zai Lab Announces Participation in November and December Investor Conferences.
ZLAB
Zai Lab Announces Participation in November and December Investor Conferences
Key Takeaway: Zai Lab Announces Participation in November and December Investor Conferences
Price reaction · baseline $26.36 (2024-10-17 close) · hit after-hours · clean, no other ZLAB news in the window
day 0 close
+4.3%
day 1
+6.2%
day 3 · peak
+9.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer